Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heartbeat clues to bladder fullness: new study explores Non-Invasive test

NCT ID NCT07607652

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new method to measure bladder fullness using heart signals. Researchers placed sticky patches (electrodes) on the body to record the heart's electrical activity during a standard bladder test. The goal was to develop a computer algorithm that could estimate bladder volume from those heart signals. The study included 30 adults with stress urinary incontinence and did not change their usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Jun 2023

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients undergoing urodynamic testing for pure stress urinary incontinence caused by urethral hypermobility

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patient undergoing urodynamic testing for pure stress urinary incontinence caused by urethral hypermobility Exclusion Criteria: * Urge urinary incontinence or mixed urinary incontinence * Bladder emptying disorder * Bladder sensory disorder * History of pelvic surgery * History of perineal surgery * History of spinal surgery * Neurological condition / dysfunction * Subjects with an implanted medical device (pacemaker, etc.) * Allergy to a component of the PC-ECG 1200 device (Norav medical ®)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female stress incontinence Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • chu de Lille

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.